A detailed history of Alta Advisers LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Alta Advisers LTD holds 4,796 shares of ABBV stock, worth $841,122. This represents 0.44% of its overall portfolio holdings.

Number of Shares
4,796
Previous 4,700 2.04%
Holding current value
$841,122
Previous $806,000 17.49%
% of portfolio
0.44%
Previous 0.39%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $15,728 - $19,135
96 Added 2.04%
4,796 $947,000
Q3 2022

Oct 28, 2022

BUY
$134.21 - $153.93 $630,787 - $723,471
4,700 New
4,700 $631,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alta Advisers LTD Portfolio

Follow Alta Advisers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Advisers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Alta Advisers LTD with notifications on news.